Publication of year-end report for the fiscal year 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2023 – June 2024. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Fourth quarter (2024-04-01 – 2024-06-30) The Group's net sales amounted to SEK 7,544,320 (38,418). The Group's profit after financial items amounted to SEK -1,111,243 (-1,896,506). Result per share amounted to SEK -0,08 (-0.12).* Fiscal year (2023-07-01 – 2024-06-30) The Group’s net sales amounted to SEK 22,447,